Literature DB >> 30008882

A meta-analysis of transcriptome datasets characterizes malignant transformation from melanocytes and nevi to melanoma.

Daniel Ortega-Bernal1, Claudia H González-De La Rosa1, Elena Arechaga-Ocampo1, Miguel Angel Alvarez-Avitia2, Nora Sobrevilla Moreno2, Claudia Rangel-Escareño3.   

Abstract

Melanoma represents one of the most aggressive malignancies and has a high tendency to metastasize. The present study aims to investigate the molecular mechanisms of two pathways to cancer transformation with the purpose of identifying potential biomarkers. Our approach is based on a meta-analysis of gene expression profiling contrasting two scenarios: A model that describes a transformation pathway from melanocyte to melanoma and a second model where transformation occurs through an intermediary nevus. Data consists of three independent, publicly available microarray datasets from the Gene Expression Omnibus (GEO) database comprising samples from melanocytes, nevi and melanoma. The present analysis identified 808 differentially expressed genes (528 upregulated and 360 downregulated) in melanoma compared with nevi, and 2,331 differentially expressed genes (946 upregulated and 1,385 downregulated) in melanoma compared with melanocytes. Further analysis narrowed down this list, since 682 differentially expressed genes were found in both models (417 upregulated and 265 downregulated). Enrichment analysis identified relevant dysregulated pathways. This article also presented a discussion on significant genes including ADAM like decysin 1, neudesin neurotrophic factor, MMP19, apolipoprotein L6, C-X-C motif chemokine ligand (CXCL)8, basic, immunoglobulin-like variable motif containing and CXCL16. These are of particular interest because they encode secreted proteins hence represent potential blood biomarkers for the early detection of malignant transformation in both scenarios. Cytotoxic T-lymphocyte associated protein 4, an important therapeutic target in melanoma treatment, was also upregulated in both comparisons indicating a potential involvement in immune tolerance, not only at advanced stages but also during the early transformation to melanoma. The results of the present study may provide a research direction for studying the mechanisms underlying the development of melanoma, depending on its origin.

Entities:  

Keywords:  biomarker; melanocyte; melanoma; meta-analysis; nevus; transcriptome

Year:  2018        PMID: 30008882      PMCID: PMC6036496          DOI: 10.3892/ol.2018.8861

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  97 in total

1.  Necessary and sufficient role for a mitosis skip in senescence induction.

Authors:  Yoshikazu Johmura; Midori Shimada; Toshinori Misaki; Aya Naiki-Ito; Hiroyuki Miyoshi; Noboru Motoyama; Naoko Ohtani; Eiji Hara; Motoki Nakamura; Akimichi Morita; Satoru Takahashi; Makoto Nakanishi
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

2.  Discrimination of Dysplastic Nevi from Common Melanocytic Nevi by Cellular and Molecular Criteria.

Authors:  Hiroshi Mitsui; Felix Kiecker; Avner Shemer; Maria Vittoria Cannizzaro; Claire Q F Wang; Nicholas Gulati; Hanako Ohmatsu; Kejal R Shah; Patricia Gilleaudeau; Mary Sullivan-Whalen; Inna Cueto; Neil Scott McNutt; Mayte Suárez-Fariñas; James G Krueger
Journal:  J Invest Dermatol       Date:  2016-07-01       Impact factor: 8.551

3.  New insights of CTLA-4 into its biological function in breast cancer.

Authors:  H Mao; L Zhang; Y Yang; W Zuo; Y Bi; W Gao; B Deng; J Sun; Q Shao; X Qu
Journal:  Curr Cancer Drug Targets       Date:  2010-11       Impact factor: 3.428

Review 4.  Human skin pigmentation: melanocytes modulate skin color in response to stress.

Authors:  Gertrude-E Costin; Vincent J Hearing
Journal:  FASEB J       Date:  2007-01-22       Impact factor: 5.191

5.  CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction.

Authors:  Elisabetta Contardi; Giulio L Palmisano; Pier Luigi Tazzari; Alberto M Martelli; Federica Falà; Marina Fabbi; Tomohiro Kato; Enrico Lucarelli; Davide Donati; Letizia Polito; Andrea Bolognesi; Francesca Ricci; Sandra Salvi; Vittoria Gargaglione; Stefano Mantero; Marco Alberghini; Giovanni Battista Ferrara; Maria Pia Pistillo
Journal:  Int J Cancer       Date:  2005-11-20       Impact factor: 7.396

6.  Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer.

Authors:  Joseph Petroziello; Andrew Yamane; Lori Westendorf; Melissa Thompson; Charlotte McDonagh; Charles Cerveny; Che-Leung Law; Alan Wahl; Paul Carter
Journal:  Oncogene       Date:  2004-10-07       Impact factor: 9.867

7.  Modulation of tryptophan catabolism by regulatory T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Kwang Woo Hwang; Ciriana Orabona; Carmine Vacca; Roberta Bianchi; Maria Laura Belladonna; Maria Cristina Fioretti; Maria-Luisa Alegre; Paolo Puccetti
Journal:  Nat Immunol       Date:  2003-10-26       Impact factor: 25.606

8.  ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.

Authors:  U-H Park; M-R Kang; E-J Kim; Y-S Kwon; W Hur; S K Yoon; B-J Song; J H Park; J-T Hwang; J-C Jeong; S-J Um
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

9.  TCTN2: a novel tumor marker with oncogenic properties.

Authors:  David Cano-Rodriguez; Susanna Campagnoli; Alberto Grandi; Matteo Parri; Elisa De Camilli; Chaojun Song; Boquan Jin; Aurelien Lacombe; Andrea Pierleoni; Mauro Bombaci; Chiara Cordiglieri; Marcel Hj Ruiters; Giuseppe Viale; Luigi Terracciano; Paolo Sarmientos; Sergio Abrignani; Guido Grandi; Piero Pileri; Marianne G Rots; Renata Grifantini
Journal:  Oncotarget       Date:  2017-08-24

10.  Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells.

Authors:  Claudia Metz; Remziye Döger; Elizabeth Riquelme; Priscilla Cortés; Christopher Holmes; Ronan Shaughnessy; Claudia Oyanadel; Catalina Grabowski; Alfonso González; Andrea Soza
Journal:  Biol Res       Date:  2016-07-27       Impact factor: 5.612

View more
  3 in total

Review 1.  Cutaneous melanoma dissemination is dependent on the malignant cell properties and factors of intercellular crosstalk in the cancer microenvironment (Review).

Authors:  Ondřej Kodet; Jan Kučera; Karolína Strnadová; Barbora Dvořánková; Jiří Štork; Lukáš Lacina; Karel Smetana
Journal:  Int J Oncol       Date:  2020-06-26       Impact factor: 5.650

Review 2.  Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician.

Authors:  Rebecca Adams; Bernhard Moser; Sophia N Karagiannis; Katie E Lacy
Journal:  Cancers (Basel)       Date:  2021-11-10       Impact factor: 6.575

Review 3.  Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process.

Authors:  Marine Melixetian; Pier Giuseppe Pelicci; Luisa Lanfrancone
Journal:  Cells       Date:  2022-02-07       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.